Globla Primary Cell Culture Industry's Vital Role in Advancing Precision Therapies and Regenerative Medicine Sparks Remarkable Growth - ResearchAndMarkets.com

The "Primary Cell Culture Market Size, Share & Trends Analysis Report By Product (Primary Cells, Reagents & Supplements, Media), By Separation Method, By Cell Type, By Application, By Region, And Segment Forecasts, 2023-2030" report has been added to ResearchAndMarkets.com's offering.

A new report indicates that the global primary cell culture market is poised for substantial growth, with an expected value of USD 11.60 billion by 2030, and a remarkable CAGR of 13.19% during the forecast period.

The surge in demand for personalized and precision therapies is a driving force behind this growth. Primary cell culture, offering a closer emulation of human biology compared to traditional cell lines, has become indispensable for understanding disease mechanisms, advancing drug discovery, and facilitating therapeutic development. Researchers and pharmaceutical companies increasingly recognize the significance of primary cell culture in improving drug candidate success rates, reducing late-stage failures, and delivering more targeted treatments to patients.

Additionally, primary cell culture is playing a pivotal role in regenerative medicine, aiming to repair or replace damaged tissues and organs. It is instrumental in creating tissue constructs, organoids, and bioengineered implants that closely mimic native tissues' structure and function. These innovations hold profound implications for regenerative medicine therapies, including tissue transplantation, wound healing, and treating degenerative diseases. For example, Mount Sinai recently established a new institute for regenerative medicine in April 2023, dedicated to exploring novel therapies for life-threatening diseases. The growing interest and investment in regenerative medicine are propelling the growth of the primary cell culture market.

The COVID-19 pandemic has also had a significant impact on the primary cell culture industry. While the pandemic disrupted various sectors, it underscored the vital role of primary cell culture in comprehending viruses and developing treatments. Primary cells have been instrumental in studying SARS-CoV-2 infection mechanisms, testing antiviral therapies, and assessing vaccine efficacy. The pandemic's urgency has fueled the demand for primary cell culture products and services, with researchers worldwide focusing on COVID-19-related studies.

Moreover, key market players have initiated various developments, and industry-academia collaborations are further boosting the global market. For example, Bio-Trac and ATCC collaborated in January 2023 to conduct a training workshop providing an overview of primary cell culture principles, organoids, spheroids, and related cell culture techniques.

Notable Companies in the Market

• Merck KGaA
• Thermo Fisher Scientific, Inc.
• Danaher Corporation
• Lonza
• PromoCell GmbH
• Corning Incorporated
• FUJIFILM Irvine Scientific
• Mattek
• Axol Bioscience Ltd
• ATCC

Key Market Highlights

• Reagent and Supplements Segment Dominates: In 2022, the reagent and supplements segment held a dominant share of 37.67%, owing to the availability of a wide range of high-quality reagents tailored for specific cell types and research applications.
• Enzymatic Degradation Leads in Separation Method: The enzymatic degradation segment led the market in 2022 with a share of 32.15%, attributed to its advantages, including minimal damage to cultures, short turnaround times, and high sample representation.
• Animal Cells Lead in Cell Types: In 2022, the animal cells segment dominated with a share of 59.41%, owing to the versatility, wide availability, and established research protocols for this cell type.
• Cell & Gene Therapy Development at the Forefront: The cell & gene therapy development segment commanded the market with a share of 39.45% in 2022, driven by the rapid growth of regenerative medicine and the escalating demand for personalized therapies.
• North America Holds Strong: North America secured a strong regional position in the global market with a 41.52% share in 2022, thanks to its highly developed healthcare infrastructure and favorable government policies.

Key Attributes:

Key Topics Covered:

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Market Variables, Trends, & Scope

3.1. Market Lineage Outlook

3.1.1. Parent Market Outlook

3.1.2. Related/Ancillary Market Outlook

3.2. Market Dynamics

3.2.1. Market Driver Analysis

3.2.1.1. Rising Usage Of Primary Cell Culture Products In In-Vitro Testing And Drug Screening

3.2.1.2. Increasing Demand For Stem Cell Therapy And Regenerative Medicine

3.2.1.3. Rising Incidence Of Cancer And Other Chronic Diseases

3.2.1.4. Advancements In Genetic Engineering Protocols

3.2.1.5. Rise In Research Funding For Functional Biology And Research

3.2.2. Market Restraint Analysis

3.2.2.1. Ethical And Regulatory Concerns Related To The Use Of Primary Cells

3.2.2.2. Finite Lifespan, Slow Growth, And Difficulties In Handling Of Primary Cultures

3.3. Industry Analysis Tools

3.3.1. Porter's Five Forces Analysis

3.3.2. PESTEL Analysis

3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Type Business Analysis

Chapter 5. Separation Method Business Analysis

Chapter 6. Cell Type Business Analysis

Chapter 7. Application Business Analysis

Chapter 8. Regional Business Analysis

Chapter 9. Competitive Landscape

For more information about this report visit https://www.researchandmarkets.com/r/ychjou

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230926569710/en/